PHF5A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.193000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.622800E-01
Normal-vs-Stage2
7.844200E-01
Normal-vs-Stage3
9.893600E-01
Normal-vs-Stage4
8.457800E-01
Stage1-vs-Stage2
6.631600E-01
Stage1-vs-Stage3
9.612600E-01
Stage1-vs-Stage4
7.916000E-01
Stage2-vs-Stage3
7.742000E-01
Stage2-vs-Stage4
9.521000E-01
Stage3-vs-Stage4
8.979800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.188600E-01
Normal-vs-AfricanAmerican
6.203400E-01
Normal-vs-Asian
9.463400E-01
Caucasian-vs-AfricanAmerican
6.664400E-01
Caucasian-vs-Asian
7.508800E-01
AfricanAmerican-vs-Asian
5.492400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.280600E-01
Normal-vs-Female
7.142000E-01
Male-vs-Female
2.268600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.220990E-01
Normal-vs-Age(41-60Yrs)
6.539600E-01
Normal-vs-Age(61-80Yrs)
8.807200E-01
Normal-vs-Age(81-100Yrs)
9.469600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.141000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.528430E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.447600E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.361600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.328600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.413200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.847800E-01
Normal-vs-Daily Drinker
8.315000E-01
Normal-vs-Weekly Drinker
4.877800E-01
Normal-vs-Occasional Drinker
5.455000E-01
Normal-vs-Social Drinker
7.905600E-01
Non Drinker-vs-Daily Drinker
6.747000E-01
Non Drinker-vs-Weekly Drinker
4.803400E-01
Non Drinker-vs-Occasional Drinker
2.315000E-01
Non Drinker-vs-Social Drinker
6.463800E-01
Daily Drinker-vs-Weekly Drinker
3.599200E-01
Daily Drinker-vs-Occasional Drinker
1.421250E-01
Daily Drinker-vs-Social Drinker
4.214800E-01
Weekly Drinker-vs-Occasional Drinker
9.981000E-01
Weekly Drinker-vs-Social Drinker
6.655200E-01
Occasional Drinker-vs-Social Drinker
4.782400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.131200E-01
Normal-vs-Grade 2
7.711200E-01
Normal-vs-Grade 3
7.695000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.014400E-02
Grade 1-vs-Grade 3
7.680000E-02
Grade 1-vs-Grade 4
7.131200E-01
Grade 2-vs-Grade 3
9.407000E-01
Grade 2-vs-Grade 4
7.711200E-01
Grade 3-vs-Grade 4
7.695000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.731400E-01
Normal-vs-NonDiabetic
7.992800E-01
Diabetic-vs-NonDiabetic
2.023800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.684200E-01
Normal-vs-NoPancreatitis
8.862200E-01
Pancreatitis-vs-NoPancreatitis
5.810400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.191400E-01
Normal-vs-N1
7.693400E-01
N0-vs-N1
7.185000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.346000E-01
Normal-vs-TP53-NonMutant
9.332800E-01
TP53-Mutant-vs-TP53-NonMutant
1.176030E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
